| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 48,630 | $30 | $1.7M |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 113,600 | $1 | $454.4K |
| J3262 | Injection, tocilizumab, 1 mg | 80,080 | $10 | $400.4K |
| J9312 | Injection, rituximab, 10 mg | 4,850 | $60 | $310.4K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 31,710 | $10 | $253.7K |
| J0897 | Injection, denosumab, 1 mg | 6,960 | $20 | $125.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 970 | $100 | $95.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 930 | $100 | $87.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 960 | $60 | $52.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 170 | $130 | $22.3K |